Irish insurer Zurich Insurance has refused consent for a class action over a defective New Zealand apartment block to proceed in the NSW Supreme Court as it mulls a High Court challenge to the case.
The CFMMEU and two of its officials have been hit with the maximum penalty for allegedly breaching right of entry rules and calling a safety advisor “disgusting homophobic slurs” at a worksite on the $5.4 billion Queensland Cross River Rail project.
Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for an early launch of a generic version of blockbuster cancer drug Revlimid.
A former Greenwoods & Freehills partner will argue he is entitled to whistleblower protection in his lawsuit against the tax advisory firm and Lendlease, alleging he was forced to leave after refusing to put his name to a tax return and making protected disclosures.
A Melbourne lawyer “driven by his own greed and ego” should be struck from the roll for at least nine years for grossly overcharged his clients and being “professionally dishonourable, blatantly dishonest and deceitful”, VCAT has found.
Chinese construction and engineering firm BCEG has won a $12 million lawsuit against two former directors of an Australian subsidiary after they allegedly swindled millions from the company to fund their own developments and buy a luxury apartment.
2XU has reached an in-principle settlement with its former head of human resources, who alleged she was fired for investigating complaints that the sportswear brand’s CEO bullied female employees and brought illicit drugs to a work function.
Investment firm Curve Securities is suing competitor Ord Minnett and a former associate director, alleging the defecting adviser solicited its clients and misused confidential information.